Vanguard Group
AH

Vanguard Group’s Accretive Health AH Stock Holding History

Vanguard Group’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,970,144
Closed -$27.2M – 3977
2013
Q4 		$27.2M Buy
2,970,144
+103,104
+4% +$887K ﹤0.01% 2052
2013
Q3 		$26.1M Buy
2,867,040
+131,479
+5% +$1.31M ﹤0.01% 2019
2013
Q2 		$29.6M Buy
+2,735,561
New +$28.8M ﹤0.01% 1918

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Vanguard Group's AH Position: Q1 2014 in Review

Vanguard Group sold out of Accretive Health (AH) in Q1 2014, closing a stake of 2,970,144 shares — an estimated $27.2M sold.

Vanguard Group first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $29.6M in Q2 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

  • Vanguard Group reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
  • Vanguard Group sold 2,970,144 Accretive Health shares in Q1 2014, an estimated $27.2M.
  • Vanguard Group first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
  • Vanguard Group's Accretive Health position peaked at $29.6M in Q2 2013.
  • 66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on Vanguard Group's 13F filing for Q1 2014, filed 13 May 2014.